Department of Pediatrics, Division of Cardiology, Rady Children's Hospital, University of California, San Diego, San Diego, California 92123, USA.
JACC Cardiovasc Interv. 2013 May;6(5):433-42. doi: 10.1016/j.jcin.2013.02.005.
This review discusses the current safety issues related to U.S. Food and Drug Administration approved atrial septal defect devices and proposes a potential avenue to gather additional safety data including factors, which may be involved in device erosion.
这篇综述讨论了与美国食品和药物管理局批准的房间隔缺损装置相关的当前安全性问题,并提出了一种收集额外安全性数据的潜在途径,包括可能涉及器械侵蚀的因素。